Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication 
3′-O-methyl UTP
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/25/2020
Carbovir triphosphate
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/25/2020
SARS-CoV-2 saRNA LNP vaccine
Potential treatment - pre-clinical evidence Experimental Vaccine Apr/25/2020
Tinzaparin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/29/2020
Nadroparin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/29/2020
Parnaparin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/29/2020
Reviparin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/29/2020
Dalteparin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/29/2020
Chondroitin sulphate C
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/29/2020
Chondroitin sulphate D
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/29/2020
Dermatan sulphate
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/29/2020
Chondroitin sulphate A
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/29/2020
Novaferon
Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/29/2020
ABBV-744
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
AC-55541
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
4E2RCat
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Silmitasertib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/30/2020
Apicidin
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Verdinexor
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
WDB002
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020